Analyst (7 of them rating it at Strong Buy/ Buy) mean target is 12.50.
Lots of drugs in the pipeline.
Have Enough cash to last for a long long time.
IPO at $5.00 discounted few cents, which means Smart money already priced it very low.
It is a cancer drug with huge potential. BUY BUY BUY. very easy decision